The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Physical activity and dexamethasone for cancer related fatigue: A preliminary placebo controlled randomized control trial.
 
Sriram Yennu
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer (Inst)
 
Vicente Valero
Honoraria - AstraZeneca; Genentech/Roche; Novartis
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Novartis
Travel, Accommodations, Expenses - Genentech/Roche
 
Brandon George Smaglo
Consulting or Advisory Role - Ipsen; Syros Pharmaceuticals
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Marker Therapeutics
(OPTIONAL) Uncompensated Relationships - Ipsen
 
Michael J. Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Eisai; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Roche/Genentech; Simcere
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Arvind Dasari
Consulting or Advisory Role - HutcMed; Illumina/GRAIL; Personalis; SIRTIS; Takeda
Research Funding - Eisai (Inst); Guardant Health (Inst); Hutchison MediPharma (Inst); Merck (Inst); Natera (Inst); XENCOR (Inst)
Travel, Accommodations, Expenses - Hutchison MediPharma; Takeda
 
Robert A. Wolff
Honoraria - Conveners; Emirates Oncology Society
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Kanwal Pratap Singh Raghav
Honoraria - Bayer; Daiichi Sankyo/Astra Zeneca; Eisai; Merck; Seagen
Consulting or Advisory Role - Bayer; Daiichi Sankyo/Astra Zeneca; Eisai; Merck; Seagen
Research Funding - Abbvie (Inst); Bayer (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); Guardant Health (Inst); HiberCell (Inst); Innovent Biologics (Inst); Janssen (Inst); Merck Serono (Inst); Roche/Genentech (Inst); UCB (Inst); Xencor (Inst)
 
Carlos Hernando Barcenas
Research Funding - Puma Biotechnology (Inst)
 
Naifa Lamki Busaidy
Honoraria - Eisai; Exelixis
Consulting or Advisory Role - Eisai; Loxo
Research Funding - GlaxoSmithKline/Novartis
 
Bryan M. Fellman
No Relationships to Disclose
 
Karen Basen-Engquist
No Relationships to Disclose
 
Debashish Tripathy
Consulting or Advisory Role - Ambrx; AstraZeneca; Genomic Health; Gilead Sciences; GlaxoSmithKline; Menarini; Novartis; OncoPep; Personalis; Pfizer; Roche; Sermonix Pharmaceuticals
Research Funding - Ambrx (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Eduardo Bruera
Research Funding - PharmaCann (Inst)